AN: Atossa Therapeutics leading clinical trial that may improve pulmonary function in COVID-19 patients ((americasnewsroom__)) ((lubuntu at wor3))

Dr. Steven Quay, physician scientist and Atossa Therapeutics CEO, joins ‘America’s Newsroom’ to explain